Treos Bio
PrivateLast Round
VC Round
Aug 27, 2025
Total Funding Raised
$42M
Company Overview
Treos Bio operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a VC Round in August 2025.
Treos Bio is a biotechnology company that develops precision peptide cancer immunotherapies and companion diagnostic tests using its proprietary computational technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Treos Bio Comparables
Compare Treos Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Geneos Therapeutics | 79% | |
| Scancell Holdings Plc | 76% | |
| Gritstone bio | 76% |
For institutional investors. Book with your work email.
Treos Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 27, 2025 | ||||
| Convertible Debt | Mar 31, 2021 | ||||
| Series A | Feb 13, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Treos Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BXR Group | Series A |
| Luminous Ventures | Convertible Debt |
| Outsized Ventures | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2025
$2.1M round raised
- Feb 13, 2017
$28M round led by BXR Group
For institutional investors. Book with your work email.
Treos Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Treos Bio's valuation, stock price, and market status.
Is Treos Bio a public or private company?
Treos Bio is a private company.
What is the current stock price of Treos Bio?
Treos Bio is a private company, so its shares have no public market price. Caplight tracks Treos Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Treos Bio worth (valuation)?
Valuation information for Treos Bio is not publicly available.
Can I buy Treos Bio stock?
Treos Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Treos Bio's last funding round?
Treos Bio's most recent funding round was VC Round on August 27, 2025.
Who are the main investors in Treos Bio?
Key investors in Treos Bio include BXR Group, Luminous Ventures.
Will Treos Bio IPO soon?
No public IPO plans have been announced for Treos Bio.
How can I track Treos Bio secondary market activity?
Caplight tracks bids, offers, and trades in Treos Bio's shares on secondary markets.